🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
To evaluate efficacy, safety and pharmacokinetic profile of asciminib 40mg+...
Status
Completed
Location
Georgia Regents University
Start Date
2018-11-22
Trial ID
NCT03578367
Treatments Being Tested
To compare the efficacy of surgery followed by sunitinib with surgery follo...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-06-02
Trial ID
NCT03424876
Treatments Being Tested
This is a phase 1 clinical trial comparing imatinib mesylate to placebo for...
Status
Completed
Location
Columbia University
Start Date
2018-01-23
Trial ID
NCT03131999
Treatments Being Tested
To evaluate the safety, efficacy and pharmacokinetics of nilotinib over tim...
Status
Completed
Location
Loma Linda University Cancer Center
Start Date
2013-08-20
Trial ID
NCT01844765
Treatments Being Tested
In a multinational, multicenter, single-arm, open-label and Phase III Radot...
Status
Recruiting
Location
Territorial State Budgetary Institution
Start Date
2018-06-25
Trial ID
NCT03459534
Treatments Being Tested
In this study, the efficacy and safety of two radotinib doses, 300 mg twice...
Status
Completed
Location
Local Institution
Start Date
2011-08
Trial ID
NCT01511289
A Phase I/II multicenter study of IY5511HCl in Philadelphia chromosome posi...
Status
Completed
Location
Local institution
Start Date
2008-07
Trial ID
NCT01602952
Treatments Being Tested
This is a efficacy and safety study of imatinib Mesylate Capsule as First l...
Status
Unknown
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02317159
Treatments Being Tested
Imatinib has revolutionized the treatment of chronic myeloid leukemia (CML)...
Status
Unknown
Location
Weiming Li
Start Date
2020-11-01
Trial ID
NCT04681820
Treatments Being Tested